1: Infections in pregnant women

Gwendolyn L Gilbert, Series Editors:
Med J Aust 2002; 176 (5): 229-236.


  • Some infections are more serious in pregnant than non-pregnant women because of the potential for vertical transmission to the fetus or infant (eg, varicella, rubella, cytomegalovirus infection, toxoplasmosis and listeriosis).

  • Pre-pregnancy or routine antenatal screening for presence of, or susceptibility to, some of these infections and appropriate management can prevent adverse fetal or perinatal outcomes; screening should include rubella IgG, hepatitis B surface antigen, serological tests for syphilis and HIV antibody.

  • If certain other vertically transmissible infections are suspected because of a positive antenatal test result, confirmatory tests for maternal and, if indicated, fetal infection are essential before intervention is considered (eg, cytomegalovirus infection).

  • For some vertically transmissible infections that are not readily preventable, appropriate management of maternal infection can reduce fetal damage (eg, toxoplasmosis).

Please login with your free MJA account to view this article in full

  • Gwendolyn L Gilbert
  • Series Editors:

  • Institute of Clinical Pathology and Medical Research, Westmead Hospital, Sydney, NSW.

  • 1. Ziegler JB. Antenatal screening for HIV in Australia: time to revise policies? Med J Aust 1999; 171: 201-203.
  • 2. Smith WJ, Jackson LA, Watts DH, Koepsell TD. Prevention of chickenpox in reproductive-age women: cost-effectiveness of routine prenatal screening with postpartum vaccination of susceptibles. Obstet Gynecol 1998; 92: 535-545.
  • 3. Gilbert GL, Isaacs D, Burgess MA, et al. Prevention of neonatal group B streptococcal sepsis: is routine antenatal screening appropriate. Aust N Z J Obstet Gynaecol 1995; 35: 120-126.
  • 4. Australia New Zealand Food Authority. Listeria and pregnancy. <> Sighted August 2005.
  • 5. Gilbert GL. Routine antenatal screening and prenatal diagnosis of vertically transmissible infection. Baillieres Clin Obstet Gynaecol 1993; 7: 1-23.
  • 6. Carusi D, Learman LA, Posner SF. Human immunodeficiency virus test refusal in pregnancy: a challenge to voluntary testing. Obstet Gynecol 1998; 91: 540-545.
  • 7. Gilbert GL. Parvovirus B19 and its significance in pregnancy. Commun Dis Intell 2000; 24: 69-71.
  • 8. Foulon W, Villena I, Stray-Pedersen B, et al. Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year. Am J Obstet Gynecol 1999; 180: 410-415.
  • 9. Heuchan AM, Isaacs D. The management of varicella zoster virus exposure and infection in pregnancy and the newborn period. Med J Aust 2001; 174: 288-292.
  • 10. Therapeutic Guidelines Limited. Therapeutic guidelines: antibiotic. Version 11, 2000. Melbourne: Therapeutic Guidelines Limited, 2000.
  • 11. Sullivan EV, Burgess MA, Forrest JM. The epidemiology of rubella and congenital rubella in Australia, 1992 to 1997. 23: 209-14. Commun Dis Intell 1999; 23: 209-214.
  • 12. Best JM, Banatvala JE, Morgan-Capner P, Miller E. Fetal infection after maternal reinfection with rubella: criteria for defining reinfection. BMJ 1989; 299: 773-775.
  • 13. Gilbert GL. Congenital (fetal) infections. Semin Neonatol 1996; 1: 91-119.
  • 14. Rousseau T, Douvier S, Reynaud I, et al. Severe fetal cytomegalic inclusion disease after documented maternal reactivation of cytomegalovirus infection during pregnancy. Prenat Diagn 2000; 20: 333-336.
  • 15. Lazzarotto T, Varani S, Guerra B, et al. Prenatal indicators of congenital cytomegalovirus infection. J Pediatrics 2000; 137: 90-95.
  • 16. Karunajeewa H, Siebert D, Hammond R, et al. Seroprevlaence of varicella zoster virus, parvovirus B19 and Toxoplasma gondii in a Melbourne obstetric population: implications for management. Aust N Z J Obstet Gynaecol 2001; 41: 23-28.
  • 17. Wallon M, Liou C, Garner P, Peyron F. Congenital toxoplasmosis: systematic review of evidence of efficacy of treatment in pregnancy. BMJ 1999; 318: 1511-1514.
  • 18. Foulon W, Pinon JM, Stray-Pedersen B, et al. Prenatal diagnosis of congenital toxoplasmosis: a multicenter evaluation of different diagnostic parameters. Am J Obstet Gynecol 1999; 181: 843-847.
  • 19. Dunn D, Wallon M, Peyron F, et al. Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 1999; 353: 1829-1833.
  • 20. Enders G, Miller E, Cradock-Watson J, et al. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet 1994; 343: 1548-1551.
  • 21. Forrest JM, Mego S, Burgess MA. Congenital and neonatal varicella in Australia. J Paediatr Child Health 2000; 36: 108-113.
  • 22. Reiff-Eldridge R, Heffner CR, Ephross SA, et al. Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries: a pharmaceutical company commitment. Am J Obstet Gynecol 2000; 182: 159-163.
  • 23. Miller E, Fairley CK, Cohen BJ, Seng C. Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol 1998; 105: 174-178.
  • 24. Fairley CK, Smoleniec JS, Caul OE, Miller E. Observational study of effect of intrauterine transfusions on outcome of fetal hydrops after parvovirus B19 infection. Lancet 1995; 346: 1335-1337.
  • 25. Kelly HA, Siebert D, Hammond R, et al. The age-specific prevalence of human parvovirus immunity in Victoria, Australia compared with other parts of the world. Epidemiol Infect 2000; 124: 449-457.
  • 26. Valeur-Jensen AK, Pedersen CB, Westergaard T, et al. Risk factors for parvovirus B19 infection in pregnancy. JAMA 1999; 281: 1099-1105.
  • 27. Daley AJ, Isaacs D, Dwyer DE, Gilbert GL. A cluster of cases of neonatal coxsackievirus B meningitis and myocarditis. J Paediatr Child Health 1998; 34: 196-198.
  • 28. Silver H. Listeriosis during pregnancy. Obstet Gynecol Survey 1998; 53: 737-740.
  • 29. Mindel A, Taylor J, Tideman RL, et al. Neonatal herpes prevention: a minor public health problem in some communities. Sex Transm Dis 2000; 76: 287-291.
  • 30. M arks C, Mindel A, Fethers K. Management of women with recurrent genital herpes in Australia. Sex Transm Dis 1999; 75: 55-57.
  • 31. Smaill F. Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database of Systematic Reviews 2000; CD000490.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Responses are now closed for this article.